Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/33570
Full metadata record
DC FieldValueLanguage
dc.contributor.authorUmaMaheswari, Thiyagamoorthy-
dc.contributor.authorHemalatha, Thiagarajan-
dc.contributor.authorSankaranarayanan, Palavesam-
dc.contributor.authorPuvanakrishnan, Rengarajulu-
dc.date.accessioned2015-12-31T04:35:16Z-
dc.date.available2015-12-31T04:35:16Z-
dc.date.issued2016-01-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/33570-
dc.description7-16en_US
dc.description.abstractEnzymes control all metabolic processes in human system from simple digestion of food to highly complex immune response. Physiological reactions occuring in healthy individuals are disturbed when enzymes are deficient or absent. Enzymes are administered for normalizing biological function in certain pathologies. Initially, crude proteolytic enzymes were used for the treatment of gastrointestinal disorders. Recent advances have enabled enzyme therapy as a promising tool in the treatment of cardiovascular, oncological and hereditary diseases. Now, a spectrum of other diseases are also covered under enzyme therapy. But, the available information on the use of enzymes as therapeutic agents for different diseases is scanty. This review details the enzymes which have been used to treat various diseases/disorders.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJEB Vol.54(01) [January 2016]en_US
dc.subjectAlginate lyaseen_US
dc.subjectAntioxidant enzymesen_US
dc.subjectAsparaginaseen_US
dc.subjectBromelainen_US
dc.subjectCardiovascularen_US
dc.subjectCollagenaseen_US
dc.subjectDNAasesen_US
dc.subjectGastrointestinalen_US
dc.subjectGlutaminaseen_US
dc.subjectHemocoagulaseen_US
dc.subjectHyaluronidaseen_US
dc.subjectLipasesen_US
dc.subjectOncologicalen_US
dc.subjectPancreatic enzymesen_US
dc.subjectRNAasesen_US
dc.subjectSerratiopeptidaseen_US
dc.subjectStreptokinaseen_US
dc.subjectTherapeuticsen_US
dc.subjectTissue plasminogen activatoren_US
dc.subjectUrokinaseen_US
dc.titleEnzyme Therapy: Current Perspectivesen_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.54(01) [January 2016]

Files in This Item:
File Description SizeFormat 
IJEB 54(1) 7-16.pdf199.97 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.